Needham & Company reiterated a Buy rating on Cardiovascular Systems (NASDAQ: CSII), and raised the price target to $27.00 (from ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments Analyst EPS Change Analyst EPS View Analyst PT Change

BofA/Merrill Lynch Upgrades Cardiovascular Systems (CSII) to NeutralAugust 4, 2016 6:51 AM Cardiovascular Systems (CSII) Tops Q4 EPS by 5c; Offers Q1 OutlookAugust 3, 2016 4:41 PM Cardiovascular Systems Reports Fiscal 2016 Fourth-Quarter Financial ResultsAugust 3, 2016 4:05 PM Trading Radar for 8/3: Tesla (TSLA), Humana (HUM), Herbalife (HLF), GoDaddy (GDDY), Metlife (MET) ReportAugust 2, 2016 2:21 PM